Quiz|Articles|January 11, 2026

Dermatology Times Spot Test: January 11, 2026

Listen
0:00 / 0:00

Key Takeaways

  • Chronic spontaneous urticaria (CSU) involves hives and/or angioedema lasting over six weeks without a known cause.
  • Autoimmunity, particularly autoantibodies, is increasingly recognized as a key factor in CSU pathogenesis.
SHOW MORE

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!

Welcome to Dermatology Times' Spot Test!

Each week, dive into a series of thought-provoking questions designed to test your understanding of essential topics, trends, and breakthroughs in dermatology. This week, we'll focus on some recent news in chronic spontaneous urticaria (CSU).

Do you have a set of quiz questions to share? Contact editor Marie Bosslett at mbosslett@mjhlifesciences.com to contribute!

In the BEACON study, what percentage of patients treated with briquilimab maintained a complete response at week 12?


In which country did families of CSU patients report the highest burden?


Ligelizumab is best described as which type of therapy?


Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


Latest CME